A Site Initiation Visit (SIV) is a crucial meeting that takes place before a clinical trial begins at a specific research site. It is conducted by the sponsor or Contract Research Organization (CRO) to ensure that the site’s staff is prepared to carry out the study according to the protocol and regulatory requirements.
During an SIV, the study team reviews important aspects of the trial, including the protocol, investigational product handling, data collection procedures, and safety reporting. The visit also serves as an opportunity to address any questions or concerns from the site staff and to confirm that all necessary resources and equipment are in place for the study to commence.
The Site Initiation Visit (SIV) is crucial in clinical research as it ensures that all participating sites are adequately prepared to conduct the study in compliance with the protocol and regulatory standards. This standardization across sites helps maintain data integrity and patient safety, which are fundamental to the success and validity of clinical trials.
SIVs also serve as a critical communication point between sponsors, CROs, and site staff, fostering a shared understanding of study objectives and procedures. By addressing potential issues and clarifying expectations before the trial begins, SIVs can significantly reduce protocol deviations and improve overall study efficiency and quality.
How Axcellant stabilized isotope supply, synchronized global imaging operations, and prevented a multi-month program delay. At a Glance Study type:…
At Axcellant, we work where medtech becomes real, not in headlines but in clinics, documentation, and decisions that must stand…
We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…
Copyright @ 2026 Axcellant